Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 9, 2019 Off

Traveler’s Diarrhea – Global Market Insights, Epidemiology and Forecast to 2028 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Traveler’s Diarrhea – Market Insights, Epidemiology and Market Forecast – 2028” drug pipelines has been added to ResearchAndMarkets.com’s…

May 9, 2019 Off

Amneal Reports First Quarter 2019 Financial Results

By BusinessWire

‒ Q1 2019 Net Revenue of $446 Million; GAAP Loss per share of $0.37; Combined Adjusted Diluted EPS(1) of $0.14…

May 9, 2019 Off

bluebird bio’s Analyst Day Highlights Commercial Path to Patients and Research Engine Focused on Next-Generation Gene and Cell Therapies

By BusinessWire

New Collaboration with Seattle Children’s Research Institute Targets New Immunotherapy Approaches to Acute Myeloid Leukemia Phase 1/2 Study for Merkel…

May 9, 2019 Off

Elanco Animal Health Reports First Quarter Results

By BusinessWire

Gross margin (reported) improved 190 basis points to 53.0 percent of revenue Earnings per share (EPS) was $0.09 (reported), or…

May 9, 2019 Off

Global Duchenne Muscular Dystrophy Market Insights, Epidemiology and Forecast 2019-2028 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Duchenne Muscular Dystrophy – Market Insights, Epidemiology and Market Forecast – 2028” drug pipelines has been added to…

May 9, 2019 Off

Acromegaly – Pipeline Insight, 2019 with Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Acromegaly – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insights…

May 9, 2019 Off

Dupixent licensed in the EU for severe asthma with type 2 inflammation

By Dino Mustafić

The European Commission (EC) has licensed Dupixent (dupilumab), developed by Regeneron and Sanofi, for older than 12 patients as an add-on maintenance treatment for severe asthma with type 2 inflammation.

May 9, 2019 Off

Dance Biopharm Appoints Kenneth B. Lee, Jr. to Board of Directors

By BusinessWire

–Financial Matters Expert to Serve as Chair of Audit Committee– SAN FRANCISCO–(BUSINESS WIRE)–Dance Biopharm Holdings, Inc., a privately-held clinical stage…

May 9, 2019 Off

Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results for Tumor Paint: BLZ-100 (tozuleristide) in Adults with Glioma

By BusinessWire

Positive Phase 1 results in adult glioma patients supported pediatric brain cancer clinical program—now in pivotal studies SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BLZ100?src=hash"…

Vibalogics increases capacity with a new 200L line for virus manufacturing
May 9, 2019 Off

Vibalogics increases capacity with a new 200L line for virus manufacturing

By Dino Mustafić

GERMANY-based contract development and manufacturing organization (CDMO) Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line to meet increasing demand for its specialist oncolytic virus and viral vector manufacturing services.

Posts pagination

Previous 1 … 3,209 3,210 3,211 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine